Peer reviewed papers

Moncrieff, J. & Middleton, H. 2015, Schizophrenia: a critical psychiatry perspective. Current Opinion in Psychiatry, 28, 264-268

The nature of mental disorder: disease, distress or personal tendency? Philosophy, Psychiatry and Psychology 2014, 21, 3 (Sept), 257-260.

Moncrieff J. (2014) ‘Freedom is more important than health’ Thomas Szasz and the problem of paternalism. International Psychiatry, 11, 46-48

Moncrieff, J. (2014) The medicalisation of ‘ups and downs’: the marketing of the new bipolar disorder. Transcultural Psychiatry, epub ahead of print, April 7th 2014 bipolar epidemic_acceptedmanuscript

Allison L, Moncrieff J. ‘Rapid tranquilisation’: an historical perspective on its emergence in the context of the development of antipsychotic medications. Hist Psychiatry. 2014 Mar;25(1):57-69. doi: 10.1177/0957154X13512573

Moncrieff, J., Cohen, D. & Porter, S. (2013) The psychoactive effects of psychiatric medications: the elephant in the room. Journal of Psychoactive Drugs, 45, 409-415.

Moncrieff, J. (2013) Magic bullets for mental disorders: the emergence of the concept of an ‘antipsychotic’ drug. Journal of the History of the Neurosciences, 22, 30-46

Moncrieff, J. & Timimi, S. (2013) The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD. Anthropology and Medicine, 20, 59-71.

Ilyas S & Moncrieff J (2012). Trends in prescriptions and costs of drugs for mental disorders in England, 1998 to 2010. British Journal of Psychiatry.200, 393-398.

Bracken, P. et al (2012) Psychiatry beyond the current paradigm. British Journal of Psychiatry, 201, 430-434.

Moncrieff, J & Timimi, S. (2011) Critical Analysis of the concept of adult attention deficit hyperactivity disorder. The Psychiatrist, 35, 334-8

Moncrieff, J. (2011) Questioning the neuroprotective hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? British Journal of Psychiatry, 198, 85-87.

Middleton, H. & Moncrieff, J (2011) A Course of Antidepressants. ‘It won’t do any harm and it might do some good’. Time to think again? British Journal of General Practice, 61, 47-49

Pillay, P and Moncrieff, J (2011) The contribution of psychiatric disorders to occupation of NHS beds: analysis of Hospital Episode Statistics. The Psychiatrist, 35,  56-59.

Goldsmith,L & Moncrieff, J. (2011). The psychoactive effects of antidepressants and their association with suicidality. Current Drug Safety, 6, 115-121.

Moncrieff, J. Rapley, M. & Timimi, S. (2011) Construction of psychiatric diagnoses: the case of adult ADHD. Journal of Critical Psychology, Counselling and Psychotherapy, 11, 16-28

Moncrieff,J. (2010) Psychiatric diagnosis as a political device. Social Theory & Health, 8, 370-382.

Moncrieff,J. & Timimi,S. (2010) Is ADHD a valid diagnosis in adults? No British Medical Jounal, 340, March 26th  , c547,

Moncrieff, J. & Leo, J. (2010) A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine, 40, 1409-22

Moncrieff J. (2009) A critique of the dopamine hypothesis of schizophrenia and psychosis. Harvard Review of Psychiatry, 17, 214-25.

Moncrieff J, Cohen D, Mason J. (2009) The subjective experience of taking antipsychotic drugs. Acta Psychiatrica Scandinavia,120, 102-11.

Moncrieff J & Cohen D (2009) How do psychiatric drugs work? British Medical Journal, May 29th, 338, 1535-1537.

Singh,D.K. & Moncrieff,J. (2009) Trends in mental health review tribunal and hospital managers hearings in north east London 1997-2007. The Psychiatrist, 33, 15-17

Moncrieff, J. (2009) The pharmaceutical industry and the construction of psychiatric diagnoses. Journal of Ethics In Mental Health, 4 (suppl), 1-4.

Moncrieff J. The Creation of the concept of an Antidepressant : An historical analysis
Social Science Medicine 2008 66 (11) : 2346-55.

Moncrieff J. Understanding psychotropic drug action: the contribution of the brain-disabling theory. Ethical Human Psychology and Psychiatry, 2007, 9, 177-187.

Moncrieff J. Co-opting psychiatry : the alliance between academic psychiatry and the pharmaceutical industry. Epidemiology Psychiatric Society  2007 – July-Sept; 16(3) : 192-6.

Moncrieff J. Are antidepressants as effective as claimed?  No, they are not effective at all. Canadian Journal of Psychiatry, 2007 Vol 52  No. 2  pp96-97.

Moncrieff J. & Kirsch I. Clinical trials and the response rate illusion. Contemp Clinical Trials   July 2007; 28(4) : 348-51.

Moncrieff J. Response to ‘A Spoonful of Regulation Helps the Medicine Go Down
Social Theory & Health (2007) 5, pp 176-179.

Moncrieff J. & Cohen D. Do antidepressants cure or create abnormal brain states?
PloS Med July 2006 ; 3(7) e240.

Moncrieff J. (2006) Does antipsychotic withdrawal provoke psychosis?  Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatrica Scandinavia, 114, 3-13.

Moncrieff J. (2006) Why is it so difficult to stop psychiatric drug treatment?  It may be nothing to do with the original problem. Medical Hypotheses 2006. 67, 517-523

Moncrieff J. (2006) Psychiatric drug promotion and the politics of neo-liberalism.
British Journal of Psychiatry, 188, 301-302.

Moncrieff J, Kirsch I (2005) Efficacy of antidepressants in adults. British Medical Journal, 331, 155-157.

Moncrieff J, Cohen D (2005) Rethinking models of psychotropic drug action. Psychother.Psychosom. 74, 145-153.

Moncrieff J, Wessely S, Hardy R (2004) Active placebos versus antidepressants for depression. Cochrane.Database.Syst.Rev. CD003012.

Timimi S, Moncrieff J, Jureidini J, Leo J, Cohen D, Whitfield C, Double D, Bindman J, Andrews H, Asen E, Bracken P, Duncan B, Dunlap M, Albert G, Green M, Greening T, Hill J, Huws R, Karon B, Kean B, McCubbin M, Miatra B, Mosher L, Parry S, DuBose RS, Riccio D, Shulman R, Stolzer J, Thomas P, Vimpani G, Wadsworth A, Walker D, Wetzel N, White R (2004) A critique of the international consensus statement on ADHD. Clin.Child Fam.Psychol.Rev. 7, 59-63.

Moncrieff J (2003) Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. Br.J.Psychiatry 183, 161-166.

Moncrieff J (2003) The politics of a new Mental Health Act. Br.J.Psychiatry 183, 8-9.

Moncrieff J (2003) A comparison of antidepressant trials using active and inert placebos. Int.J.Methods Psychiatr.Res. 12, 117-127.

Moncrieff J (2002) The antidepressant debate. Br.J.Psychiatry 180, 193-194.

Moncrieff J, Crawford MJ (2001) British psychiatry in the 20th century–observations from a psychiatric journal. Soc.Sci.Med. 53, 349-356.

Moncrieff J, Wessely S, Hardy R (2001) Antidepressants using active placebos. Cochrane.Database.Syst.Rev. CD003012.

Moncrieff J (2001) Are antidepressants overrated? A review of methodological problems in antidepressant trials. J.Nerv.Ment.Dis. 189, 288-295.

Moncrieff J, Churchill R, Drummond C, McGuire H (2001) Development of a quality assessment instrument for trials of treatments of depression and neurosis. Int. J Methods Psychiatr Res. 10, 126-133.

Moncrieff J, Pomerleau J (2000) Trends in sickness benefits in Great Britain and the contribution of mental disorders. J.Public Health Med. 22, 59-67.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B (2000) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35, 587-593.

Lima MS, Moncrieff J (2000) A comparison of drugs versus placebo for the treatment of dysthymia. Cochrane.Database.Syst.Rev.  CD001130.

Moncrieff J (1999) An investigation into the precedents of modern drug treatment in psychiatry. Hist Psychiatry 10, 475-490.

Moncrieff J (1999) “The Defeat Depression Campaign and trends in sickness and invalidity benefits for depressive illness” Journal of Mental Health, 8, 195-202.

Moncrieff J & Smyth M (1999) “Community Treatment orders-a bridge too far?” Psychiatric Bulletin, 23, 1-3.

Moncrieff J, Wessely S, Hardy R (1998) Meta-analysis of trials comparing antidepressants with active placebos. Br.J.Psychiatry 172, 227-231.

Moncrieff J, Drummond DC (1998) The quality of alcohol treatment research: an examination of influential controlled trials and development of a quality rating system. Addiction 93, 811-823.

Moncrieff J, Farmer R (1998) Sexual abuse and the subsequent development of alcohol problems. Alcohol Alcohol  33, 592-601.

Moncrieff J (1998) “The genetics of human behaviour-explanation or ideology?” Psychiatric Bulletin, 22, 158-161.

Moncrieff J, Drummond DC (1997) New drug treatments for alcohol problems: a critical appraisal. Addiction 92, 939-947.

Moncrieff J (1997) Lithium: evidence reconsidered. Br.J.Psychiatry 171, 113-119.

Moncrieff J, Drummond DC, Candy B, Checinski K, Farmer R (1996) Sexual abuse in people with alcohol problems. A study of the prevalence of sexual abuse and its relationship to drinking behaviour. Br.J.Psychiatry 169, 355-360.

Moncrieff J (1995) Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br.J.Psychiatry 167, 569-573.

Book chapters:

Moncrieff, J, Cohen D, Mason, J. (in press) The patient’s dilemma: an analysis of users’ experiences of taking neuroleptic drugs. In edited book, Editors R. Diamond, S.Coles

Moncrieff (in press). Edited textbook of critical psychology

Moncrieff J. (2010) Deconstructing psychiatric drug treatment. In Mental Health Still Matters, 2nd Edition, Open University Press

Moncrieff J. (2008) Neoliberalism and biopsychiatry: a marriage of convenience. In Liberatory Psychiatry. Eds C. Cohen & S. Timimi, CUP, P235-257.

Moncrieff, J. (2007) The politics of psychiatric drug treatment. In Critical Psychiatry ed Double D. Palgrave Macmillan, London.

Moncrieff J, Byrne P, Crawford M (2005). Challenges to Psychiatry: antipsychiatry, the user movement and stigma. In Core Psychiatry second edition, Eds Wright P, Stern J, Phelan M. Elsevier Ltd, London.
Updated for third edition, 2010

Moncrieff J (2003) Research Synthesis: systematic reviews and meta-analysis. In Prince et al (eds) Practical Psychiatric Epidemiology, OUP, Oxford.


Other publications:

Moncrieff, J (2010) The truth about psychiatric drugs. Asylum magazine, March 2010.

Moncrieff, J (2009) The myth of the chemical cure
Viewpoint for BBC’s Scrubbing Up health column

Moncrieff J. (2008) The truth about psychiatric drugs
Openmind  2008. No. 151 May/June pp 6-11.

Moncrieff, J. (2008) The myth of the magic antipsychotic.

Mental Health Today, June, 18-22.

Moncrieff J. (2007) Diagnosis and drug treatment
The Psychologist – May 2007 Vol.20  No. 5.

Moncrieff J. (2006) An Unholy Alliance :
Psychiatry and the influence of the pharmaceutical industry
Asylum magazine 2006 UK.  PP 14-16.

Moncrieff J. Is the antidepressant era coming to an end?
DR MEDICINE 13 Sept 2005 PP27-31

Moncrieff J, Hopker S, Thomas P (2005) Psychiatry and the pharmaceutical industry: who pays the piper? Psychiatric Bulletin, 29, 84-85.

Moncrieff J, Double D (2003) Double blind random bluff.  Ment.Health Today 24-26.

Moncrieff J. Is Psychiatry for Sale?  (2003) An examination of the influence of the pharmaceutical industry on academic and practical psychiatry.

Maudsley Discussion paper  ISBN 0-9500289-9-1 June 2003  pp 1-32.

Thomas P and Moncrieff J (2000) “What is Critical Psychiatry?”, Health Matters, February 2000.

Moncrieff J (1998) “Research synthesis: systematic reviews and meta-analysis.” International Review of Psychiatry, 10, 304-311.

Moncrieff J (1997) Expert commentary on “Meta-analysis of SSRI’s versus tricyclic antidepressants for treatment of depression.” Evidence Based Medicine, 1997.

Moncrieff J (1997) Book review of “The psychopharmacologists. A collection of interviews by David Healy”, Psychological Medicine, 27, 1453-1454.

Moncrieff J (1997) “The medicalisation of modern living” Soundings, summer 1997, 63-72.



Moncrieff J., Thomas P., Huws R (2008) Some Progress in UK psychiatry
British Medical Journal  2008; 337 : a1780.

Moncrieff J (2005) Selective serotonin reuptake inhibitors: evidence base for older antidepressants is shaky too. BMJ 330, 420.

Moncrieff J (2003) Antidepressant prescribing and suicide: Analysis is misleading. BMJ 327, 288.

Moncrieff J, Thomas P (2002) The pharmaceutical industry and disease mongering. Psychiatry should not accept so much commercial sponsorship. BMJ 325, 216.

Moncrieff J, Thomas P, Crawford M, Henderson C. (1999) “Modernising mental health services: Psychiatrists should oppose community treatment orders” BMJ, 318, 807.

Moncrieff J (1999) Clinical review overstates genetic case for schizophrenia. BMJ 319, 1498-1499.

Moncrieff J (1999) Naturalistic treatment study of depression in general practice. Antidepressants are overrated. BMJ 319, 921-922.

Moncrieff J, Thomas P, Crawford M, Henderson C (1999) Modernising mental health services. Psychiatrists should oppose community treatment orders. BMJ 318, 807.

Moncrieff, J. (1998) “40 years of lithium treatment” Archives of General Psychiatry, 55, 92-3.

Moncrieff J, Wessely S (1998) Active placebos in antidepressant trials. Br.J.Psychiatry 173, 88.

Moncrieff J (1996) Lithium revisited. Br.J.Psychiatry 168, 789.

Moncrieff J (1996) ‘Audible thoughts’ and ‘speech defect’. Br.J.Psychiatry 169, 249-250.

Moncrieff J (1994) Association between sexual and substance abuse. Br.J.Psychiatry 164, 847.